***LEVON NEEDS IMMEDIATE MEDICAL SUPPORT***

 Levon has been battling acute myeloblastic leukemia since August 2023. 

This diagnosis was yet another crisis this family has suffered since 2017, when his youngest sister was diagnosed with acute lymphoblastic leukemia. 

She endured more than 2 years of intense treatment, only for the family to then lose their home in Artsakh during the 44-Day War.

 

 

On June 4, 2024, he underwent a complex stem cell transplant. However, shortly after the procedure, Levon faced a new challenge — a severe post-transplant complication known as GVHD (Graft-Versus-Host Disease). This occurs when the donor’s immune cells attack the recipient’s body — in Levon’s case, damaging his liver and skin.

Without ongoing targeted therapy, this condition can become fatal.

Levon must take two life-saving medications daily: 
• Ruxolitinib, a targeted therapy that helps control GVHD and reduce inflammation,
• Belumosudil, used to treat skin GVHD and prevent further organ damage and spread of the disease.

These medications are essential for Levon’s recovery but come with a heavy financial burden his family cannot manage alone.

LEARN MORE ABOUT LEVON  

 

---

 HELP US GIVE LEVON A BRIGHT FUTURE!

 

Thank you for your continued support of SOAR and our initiatives. Direct any inquiries you may have to gyacoubian@soar-us.org.

The Society for Orphaned Armenian Relief is the world's only charitable organization devoted exclusively to helping orphaned Armenian children. SOAR is a 501(c)(3) nonprofit organization, and your donation is tax-deductible to the full extent allowed by law. Visit here to learn more about SOAR's distribution methods and quality control protocol.